J. C. Reverter

Combined type‐1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour

J. Yagüe, M. Sans, J. Panés, 2006, Alimentary pharmacology & therapeutics.

Concentrates containing factor IX could improve haemostasis under conditions of thrombocytopenia: studies in an in vitro model

A. Galán, G. Escolar, J. Reverter, 2002, Vox sanguinis.

The 4G/4G genotype of the 4G/5G polymorphism of the type‐1 plasminogen activator inhibitor (PAI‐1) gene is a determinant of penetrating behaviour in patients with Crohn's disease

M. Sans, G. Espinosa, J. Panés, 2003, Alimentary pharmacology & therapeutics.